Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01702948 · ClinicalTrials.gov registry record

Studying Nicotine Addiction With Transcranial Magnetic Stimulation

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
46
Enrollment target

NCT01702948: Completed study, sponsored by National Institute on Drug Abuse (NIDA).

NCT01702948 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01702948 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
46 participants
Enrollment target

Study Summary

Background: \- Nicotine addiction often makes it difficult to stop smoking. Researchers want to understand the areas of the brain that are important in nicotine addiction. They will use a type of brain stimulation called repetitive transcranial magnetic stimulation (rTMS) to look at part of the brain that may be involved in nicotine addiction. They will see how these areas affect brain function, thinking, and decision making. For this study, rTMS will first be tested on nonsmokers, then smokers will be recruited at a later time. Objectives: \- To study areas of the brain involved in nicotine addiction. Eligibility: \- Individuals at least 18 years of age who do not smoke. Design: * Participants will be screened with a physical exam and medical history. They will also provide a urine sample. * There will be four study sessions. The first session will involve a magnetic resonance imaging (MRI) scan. The other three visits will involve rTMS and MRI scans. * The first MRI scan will take a baseline picture of the brain. Participants will also practice the tasks for the other three sessions in a mock scanner. * At the next three visits, participants will have rTMS and MRI scans. Two visits will involve rTMS; the other visit will involve mock rTMS with no actual magnetic stimulation. During the MRI scans, participants will perform tasks that involve decision making.

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2012-09-10
Est. Completion 2017-10-03

What the finished NCT01702948 record still lists

NCT01702948 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01702948 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01702948 about?

NCT01702948 is a clinical study titled "Studying Nicotine Addiction With Transcranial Magnetic Stimulation". Background: \- Nicotine addiction often makes it difficult to stop smoking. Researchers want to understand the areas of the brain that are important in nicotine addiction. They will use a type of brain stimulation called repetitive transcranial magnetic stimulation (rTMS) to look at part of the bra...

What is the current status of trial NCT01702948?

This trial is currently completed. The enrollment target is 46 participants. The study started on 2012-09-10. Estimated completion is 2017-10-03.

Who is sponsoring clinical trial NCT01702948?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01702948, the US trial registry maintained by the National Library of Medicine. NCT01702948 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.